PDEX vs ZBH
PDEX: Pro-Dex designs and manufactures precision surgical handpieces and medical devices, while expanding into aerospace machining through its recent acquisition of APM. ZBH: A global medical device company focused on musculoskeletal healthcare, including orthopedic implants and advanced surgical technologies.
Side-by-side fundamentals
| Metric | PDEX | ZBH | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $62.21 | $88.88 | |
| Market cap | $199M | $17.0B | |
| P/E as of 2026-10-08 | 17.16 | 21.63 | PDEX lower |
| Net margin | +17.6% | +8.6% | PDEX higher |
| Gross margin FY2026, SEC XBRL | +31.4% | n/a | |
| Operating margin | +16.8% | +13.3% | PDEX higher |
| ROE | +28.7% | +5.5% | PDEX higher |
| ROA | +18.3% | +3.1% | PDEX higher |
| Debt / equity as of 2026-09-02 | 0.41 | 0.59 | PDEX lower |
| Revenue growth (YoY) as of 2026-09-02 | +16.4% | +8.6% | PDEX higher |
| Revenue CAGR (3y) SEC XBRL | +18.9% | +5.9% | PDEX higher |
| Dividend yield as of 2026-09-02 | n/a | +1.0% | |
| Dividend streak (yrs) SEC XBRL | 0 | 15 | ZBH higher |
| Beta as of 2026-09-02 | 0.70 | 0.29 | |
| 1-year return as of 2026-10-08 close | +79.1% | -9.6% | PDEX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.